Other grades of this product :
| HUMAN PAI-1 Basic information |
| Product Name: | HUMAN PAI-1 | | Synonyms: | PLASMINOGEN ACTIVATOR INHIBITOR-1, MUTANT, HUMAN;PLASMINOGEN ACTIVATOR INHIBITOR-1, MUTANT, HUMAN, RECOMBINANT;PAI-1, MUTANT;PAI-1, MUTANT, HUMAN;HUMAN PAI-1;HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1;PAIE;PLANH1 | | CAS: | 140208-23-7 | | MF: | | MW: | 0 | | EINECS: | | Product Categories: | | Mol File: | Mol File |
| HUMAN PAI-1 Chemical Properties |
| storage temp. | -20°C | | form | lyophilized powder |
| WGK Germany | 2 | | HS Code | 3504009000 |
| HUMAN PAI-1 Usage And Synthesis |
| Uses | Plasminogen activator inhibitor 1 (PAI-1) human has been used: - as an inhibitor of pro-brain-derived neurotrophic factor (proBDNF) in radioimmunoprecipitation assay (RIPA) in peripheral blood and lymphocytes
- to block plasmin activation in mice infected with C. albicans hyphae
- to test its effect on neurite growth in neurons
| | General Description | Plasminogen activator inhibitor 1 (PAI-1) or serine protease inhibitor E1 (SERPINE1) gene is mapped to human chromosome 7q22.1. PAI-1 is produced in hepatocytes, endothelial cells, smooth muscle cells, megakaryocytes, and adipocytes. | | Biochem/physiol Actions | Plasminogen Activator Inhibitor 1 (PAI-1) protein belongs to the Serpin superfamily of serine protease inhibitors. It is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and therefore inhibits the fibrinolysis process. PAI is involved in extracellular matrix remodeling and has been implicated in processes like angiogenesis, chemotaxis, ovulation, and embryogenesis. PAI-1 is present in increased levels in various disease states such as a number of cancer forms, obesity and the metabolic syndrome. |
| HUMAN PAI-1 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye